PCR-restriction fragment length polymorphism for rapid, low-cost identification of isoniazid-resistant Mycobacterium tuberculosis

Journal of Clinical Microbiology

Volumn 45, Issue 6, 2007, Pages 1789-1793

  Caws, Maxine ^a,d   Dau, Quang Tho ^a   Phan, Minh Duy ^a   Lan, Nguyen Thi Ngoc ^b   Dai, Viet Hoa ^b   Torok, Mili Estee ^a,d   Chau, Tran Thi Hong ^c   Chau, Nguyen Van Vinh ^c   Nguyen, Tran Chinh ^c   Farrar, Jeremy ^a,d  

^a OXFORD UNIVERSITY CLINICAL RESEARCH UNIT   (Viet Nam)

^b Pham Ngoc Thach Hospital for Tuberculosis and Lung Disease   (Viet Nam)

^c UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^d CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; RESTRICTION ENDONUCLEASE;

ARTICLE; BACTERIAL GENE; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BACTERIUM MUTANT; CODON; COST; DNA EXTRACTION; DRUG RESISTANCE; DRUG SENSITIVITY; HOSPITAL; KATG GENE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS; VIET NAM;

MYCOBACTERIUM TUBERCULOSIS;

EID: 34250673162     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.01960-06     Document Type: Article

References (30)

1. Aragon, L. M., F. Navarro, V. Heiser, M. Garrigo, M. Espanol, and P. Coll. 2006. Rapid detection of specific gene mutations associated with isoniazid or rifampicin resistance in Mycobacterium tuberculosis clinical isolates using non-fluorescent low-density DNA microarrays. J. Antimicrob. Chemother. 57:825-831.
2. Baker, L. V., T. J. Brown, O. Maxwell, A. L. Gibson, Z. Fang, M. D. Yates, and F. A. Drobniewski. 2005. Molecular analysis of isoniazid-resistant Mycobacterium tuberculosis isolates from England and Wales reveals the phylogenetic significance of the ahpC -46A polymorphism. Antimicrob. Agents Chemother. 49:1455-1464.
3. Caws, M., P. M. Duy, D. Q. Tho, N. T. Lan, D. V. Hoa, and J. Farrar. 2006. Mutations prevalent among rifampin- and isoniazid-resistant Mycobacterium tuberculosis isolates from a hospital in Vietnam. J. Clin. Microbiol. 44:2333-2337.
4. Coll, P., L. M. Aragon, F. Alcaide, M. Espasa, M. Garrigo, J. Gonzalez, J. M. Manterola, P. Orus, and M. Salvado. 2005. Molecular analysis of isoniazid and rifampin resistance in Mycobacterium tuberculosis isolates recovered from Barcelona. Microb. Drug Resist. 11:107-114.
5. Escalante, P., S. Ramaswamy, H. Sanabria, H. Soini, X. Pan, O. Valiente-Castillo, and J. M. Musser. 1998. Genotypic characterization of drug-resistant Mycobacterium tuberculosis isolates from Peru. Tuber Lung Dis. 79:111-118.
6. Haas, W. H., K. Schilke, J. Brand, B. Amthor, K. Weyer, P. B. Fourie, G. Bretzel, V. Sticht-Groh, and H. J. Bremer. 1997. Molecular analysis of katG gene mutations in strains of Mycobacterium tuberculosis complex from Africa. Antimicrob. Agents Chemother. 41:1601-1603.
7. Hazbon, M. H., M. Brimacombe, M. Bobadilla del Valle, M. Cavatore, M. I. Guerrero, M. Varma-Basil, H. Billman-Jacobe, C. Lavender, J. Fyfe, L. Garcia-Garcia, C. I. Leon, M. Bose, F. Chaves, M. Murray, K. D. Eisenach, J. Sifuentes-Osornio, M. D. Cave, A. Ponce de Leon, and D. Alland. 2006. Population genetics study of isoniazid resistance mutations and evolution of mu)tidrug-resistant Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 50:2640-2649.
8. Huong, N. T., B. D. Duong, N. V. Co, H. T. Quy, L. B. Tung, M. Bosnian, A. Gebhardt, J. P. Velema, J. F. Broekmans, and M. W. Borgdorff. 2005. Establishment and development of the National Tuberculosis Control Programme in Vietnam. Int. J. Tuberc. Lung Dis. 9:151-156.
9. Leung, E. T., K. M. Kam, A. Chiu, P. L. Ho, W. H. Seto, K. Y. Yuen, and W. C. Yam. 2003. Detection of katG Ser315Thr substitution in respiratory specimens from patients with isoniazid-resistant Mycobacterium tuberculosis using PCR-RFLP. J. Med. Microbiol. 52:999-1003.
10. Makinen, J., H. J. Marttila, M. Marjamaki, M. K. Viljanen, and H. Soini. 2006. Comparison of two commercially available DNA line probe assays for detection of multidrug-resistant Mycobacterium tuberculosis. J. Clin. Microbiol. 44:350-352.
11. Marttila, H. J., H. Soini, P. Huovinen, and M. K. Viljanen. 1996. katG mutations in isoniazid-resistant Mycobacterium tuberculosis isolates recovered from Finnish patients. Antimicrob. Agents Chemother. 40:2187-2189.
12. Mokrousov, I., T. Otten, M. Filipenko, A. Vyazovaya, E. Chrapov, E. Limeschenko, L. Steklova, B. Vyshnevskiy, and O. Narvskaya. 2002. Detection of isoniazid-resistant Mycobacterium tuberculosis strains by a multiplex allele-specific PCR assay targeting katG codon 315 variation. J. Clin. Microbiol. 40:2509-2512.
13. Park, H., E. J. Song, E. S. Song, E. Y. Lee, C. M. Kim, S. H. Jeong, J. H. Shin, J. Jeong, S. Kim, Y. K. Park, G. H. Bai, and C. L. Chang. 2006. Comparison of a conventional antimicrobial susceptibility assay to an oligonucleotide chip system for detection of drug resistance in Mycobacterium tuberculosis isolates. J. Clin. Microbiol. 44:1619-1624.
14. Piersimoni, C., A. Olivieri, L. Benacchio, and C. Scarparo. 2006. Current perspectives on drug susceptibility testing of Mycobacterium tuberculosis complex: the automated nonradiometric systems. J. Clin. Microbiol. 44:20-28.
15. Quy, H. T., T. N. Buu, F. G. Cobelens, N. T. Lan, C. S. Lambregts, and M. W. Borgdorff. 2006. Drug resistance among smear-positive tuberculosis patients in Ho Chi Minh City, Vietnam. Int. J. Tuberc. Lung Dis. 10:160-166.
16. Quy, H. T., F. G. Cobelens, N. T. Lan, T. N. Buu, C. S. Lambregts, and M. W. Borgdorff. 2006. Treatment outcomes by drug resistance and HIV status among tuberculosis patients in Ho Chi Minh City, Vietnam. Int. J. Tuberc. Lung Dis. 10:45-51.
17. Quy, H. T., N. T. Lan, M. W. Borgdorff, J. Grosset, P. D. Linh, L. B. Tung, D. van Soolingen, M. Raviglione, N. V. Co, and J. Broekmans. 2003. Drug resistance among failure and relapse cases of tuberculosis: is the standard re-treatment regimen adequate? Int. J. Tuberc. Lung Dis. 7:631-636.
18. Ramaswamy, S. V., R. Reich, S. J. Dou, L. Jasperse, X. Pan, A. Wanger, T. Quitugua, and E. A. Graviss. 2003. Single nucleotide polymorphisms in genes associated with isoniazid resistance in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 47:1241-1250.
19. Rindi, L., L. Bianchi, E. Tortoli, N. Lari, D. Bonanni, and C. Garzelli. 2005. Mutations responsible for Mycobacterium tuberculosis isoniazid resistance in Italy. Int. J. Tuberc. Lung Dis. 9:94-97.
20. Telenti, A., N. Honore, C. Bernasconi, J. March, A. Ortega, B. Heym, H. E. Takiff, and S. T. Cole. Genotypic assessment of isoniazid and rifampin resistance in Mycobacterium tuberculosis: a bind study at reference laboratory level. J. Clin. Microbiol. 35:719-723.
21. Temesgen, Z., K. Satoh, J. R. Uhl, B. C. Kline, and F. R. Cockerill III. 1997. Use of polymerase chain reaction single-strand conformation polymorphism (PCR-SSCP) analysis to detect a point mutation in the catalase-peroxidase gene (katG) of Mycobacterium tuberculosis. Mol. Cell Probes 11:59-63.
22. Traore, H., K. Fissette, I. Bastian, M. Devleeschouwer, and F. Portaels. 2000. Detection of rifampicin resistance in Mycobacterium tuberculosis isolates from diverse countries by a commercial line probe assay as an initial indicator of multidrug resistance. Int. J. Tuberc. Lung Dis. 4:481-484.
23. van Doorn, H. R., E. C. Claas, K. E. Templeton, A. G. van der Zanden, A. te Koppele Vije, M. D. de Jong, J. Dankert, and E. J. Kuijper. 2003. Detection of a point mutation associated with high-level isoniazid resistance in Mycobacterium tuberculosis by using real-time PCR technology with 3′-minor groove binder-DNA probes. J. Clin. Microbiol. 41:4630-4635.
24. van Doom, H. R., P. E. de Haas, K. Kremer, C. M. Vandenbroucke-Grauls, M. W. Borgdorff, and D. van Soolingen. 2006. Public health impact of isoniazid-resistant Mycobacterium tuberculosis strains with a mutation at amino-acid position 315 of katG: a decade of experience in The Netherlands. Clin. Microbiol. Infect. 12:769-775.
25. van Soolingen, D., P. E. de Haas, H. R. van Doorn, E. Kuijper, H. Rinder, and M. W. Borgdorff. 2000. Mutations at amino acid position 315 of the katG gene are associated with high-level resistance to isoniazid, other drug resistance, and successful transmission of Mycobacterium tuberculosis in the Netherlands. J. Infect. Dis. 182:1788-1790.
26. Victor, T. C., A. M. Jordaan, A. van Rie, G. D. van der Spuy, M. Richardson, P. D. van Helden, and R. Warren. 1999. Detection of mutations in drug resistance genes of Mycobacterium tuberculosis by a dot-blot hybridization strategy. Tuber Lung Dis. 79:343-348.
27. Watterson, S. A., S. M. Wilson, M. D. Yates, and F. A. Drobniewski. 1998. Comparison of three molecular assays for rapid detection of rifampin resistance in Mycobacterium tuberculosis. J. Clin. Microbiol. 36:1969-1973.
28. Wojtyczka, R. D., S. Dworniczak, J. Pacha, D. Idzik, M. Kepa, Z. Wydmuch, S. Glab, M. Bajorek, K. Oklek, and J. Kozielski. 2004. PCR-RFLP analysis of a point mutation in codons 315 and 463 of the katG gene of Mycobacterium tuberculosis isolated from patients in Silesia, Poland. Pol. J. Microbiol. 53:89-93.
29. Zhang, Y., B. Heym, B. Allen, D. Young, and S. Cole. 1992. The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis. Nature 358:591-593.
30. Zignol, M., M. S. Hosseini, A. Wright, C. L. Weezenbeek, P. Nunn, C. J. Watt, B. G. Williams, and C. Dye. 2006. Global incidence of multidrug-resistant tuberculosis. J. Infect. Dis. 194:479-485.